Published by the NYC Health Department, 2015.
Hep Free NYC supports the Immunization Action Coalition’s National Hep B Birth Dose Honor Roll initiative. NYC Hep B Universal Birth Dose Initiative aims to gather support for the hepatitis B birth dose in New York City.
Last Updated on January 25, 2020 by HepFree NYC
The Hepatitis A, B and C in NYC: 2021 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
YSDOH Drug Utilization Review Board meeting, the board voted to approve Viekira Pak as its preferred drug for persons chronically infected with HCV and enrolled in FFS Medicaid. Viekira Pak will be available for all chronically infected persons regardless of disease severity. Thi...
New Yorkers are being forced to use mail order pharmacies for many medications despite their clear preference to obtain their prescriptions from a local pharmacy.
On February 26th, the New York State Drug Utilization Review Board will meet to review and recommend NYS Medicaid clinical criteria for Viekira Pak - the most recently approved Hepatitis C therapy - marketed by AbbVie.
The purpose of this letter is to inform OB/GYN providers of the Centers for Disease Control and Prevention and U.S. Preventive Services Task Force hepatitis C virus (HCV) screening recommendations for adults and pregnant persons.
Organizations wishing to receive City Council funding in FY 2019 must complete Discretionary Funding application by February 20, 2018.
Project INSPIRE provides care coordination to HCV patients and a web‐based training program (telementoring) on disease management and treatment by HCV specialists to primary care providers inexperienced in HCV treatment.
City Council demonstrated its commitment to hepatitis elimination by continuing support for the Viral Hepatitis Initiative, which has improved health care access for over 8,000 New Yorkers at risk for or living with hepatitis B or C, and trained over 800 clinical providers.
){kind=link}